Abetimus sodium: a medication for the prevention of lupus nephritis flares

Author： Horowitz Diane M Furie Richard A

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.9, 2009-06, pp. : 1501-1507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease

By Cardiel Mario H

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 77-88

Informa Healthcare

Access to resources Recommend Favorite

LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus

By Mosca Marta Baldini Chiara Bombardieri Stefano

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 873-879

Informa Healthcare

Access to resources Recommend Favorite

Animal Models of Lupus and Lupus Nephritis

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2320-2349

Bentham Science Publishers

Access to resources Recommend Favorite

Infliximab: Lupus nephritis: case report

Reactions Weekly, Vol. 1, Iss. 1243, 2009-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Etanercept: Lupus nephritis: case report

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite